TNXP

Tonix Pharmaceuticals Holding Corp.

Healthcare Pharmaceutical Preparations Market cap: $98.3M All insider activity → Quote and statistics → Sign in to watch TNXP Sign in to set a price alert

AI summary Tonix Pharmaceuticals insiders buy open-market shares following second GPO commercial payer agreement for TONMYA.

Insider Score Band 60–79

Research score: 64
AI adjustment: +9

Research score, not a recommendation.

Total bought$132.1K3 Form 4 purchases

Distinct insiders3open-market buyers

Lead insiderLEDERMAN SETHCEO

Cluster window2026-06-08 → 2026-06-12active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders

37%

Seniority executive rank of buyers (CEO/CFO/Director)

91%

Commitment purchase size relative to company & holdings

77%

Context buying into stock weakness signals conviction

100%

Timing coordinated purchases within a tight window

99%

Routine-purchase discount × 1.00

Company-type / offering discount × 1.00

Net insider selling penalty − 0

Why are they buying?

AI · discretionary · catalyst credible · documented

Company insiders including the CEO and directors made open-market purchases shortly after Tonix announced a second commercial group purchasing organization agreement expanding TONMYA coverage to approximately 52 million U.S. lives.

The open-market purchases followed the June 8, 2026 press release regarding the new commercial payer agreement, demonstrating insider alignment during the commercial ramp-up of their flagship fibromyalgia product.

Filing references and sources

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives (opens in a new tab)

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

3 Form 4 trades · 3 insiders Sign in to download CSV

Purchases in this cluster, grouped by insider, largest first
Date	Insider	Role	Shares	Price	Value	Filing
2026-06-09	LEDERMAN SETH 27 purchases with a 63-day result · median -40.8%	CEO	5,000	$11.79	$58.9K	SEC filing for LEDERMAN SETH (opens in a new tab)
2026-06-08	Stillwell Richard Newcomb history of Stillwell Richard Newcomb's purchases	Director	5,000	$11.65	$58.2K	SEC filing for Stillwell Richard Newcomb (opens in a new tab)
2026-06-12	Taylor Carolyn E. history of Taylor Carolyn E.'s purchases	Director	1,415	$10.55	$14.9K	SEC filing for Taylor Carolyn E. (opens in a new tab)
Total					$132.1K

Other buying runs at TNXP

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days +1.6%63 days +2.9%126 days –

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window	Insiders	Total	Score	21 days	63 days	126 days	Status
2020-08-13 → 2020-08-31	6	$104.0K	64	-16.2%	-52.8%	+13.8%	closed
2018-05-25 → 2018-06-29	6	$173.8K	58	+9.2%	-84.4%	-77.4%	closed